Sebastiano Scalzo
Sebastiano Scalzo publishes mostly in Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism, on topics such as Heart Failure Treatment and Management, Acute Myocardial Infarction Research and Cardiovascular Function and Risk Factors.
- World rank
- #5,967,250 of 7,710,434 ranked researchers
- Rank in Italy
- #198,201 of 242,206
- Works
- 43
- Citations
- 573
- Citations per work
- 13.3
What does Sebastiano Scalzo research?
Sebastiano Scalzo's work is mostly in Medicine (68%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences2967.5%
- Medicine2967.5%
- Everything else1432.5%
- 1Cardiology and Cardiovascular Medicine40% of their works
- 2Surgery8% of their works
- 3Endocrinology, Diabetes and Metabolism7% of their works
- 4Pulmonary and Respiratory Medicine5% of their works
- 5Rheumatology4% of their works
- 6Urology3% of their works
Research topics
- Heart Failure Treatment and Management
- Acute Myocardial Infarction Research
- Cardiovascular Function and Risk Factors
- Pelvic floor disorders treatments
- Coronary Interventions and Diagnostics
- Cardiac electrophysiology and arrhythmias
- Hormonal Regulation and Hypertension
- Venous Thromboembolism Diagnosis and Management
Which keywords describe Sebastiano Scalzo's research?
The keywords of their largest research topics: Cardiovascular Disease, Guidelines, Heart Failure, Epidemiology, Diagnosis, Treatment, B-Type Natriuretic Peptide and Hospital Readmission.
- Venous Thromboembolism
- Long-QT Syndrome
- Antithrombotic Therapy
- Urinary Incontinence
- Myocardial Revascularization
- Echocardiography
- Myocardial Infarction
- Hospital Readmission
- Treatment
- Epidemiology
- Guidelines
- Cardiovascular Disease
- Heart Failure
- Diagnosis
- B-Type Natriuretic Peptide
- Acute Coronary Syndromes
- Chamber Quantification
- Coronary Stents
- Pelvic Floor Dysfunction
- Aldosterone
- Arrhythmias
- Primary Aldosteronism
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Cardiovascular Disease222 topics
- Guidelines222 topics
- Heart Failure182 topics
- Epidemiology172 topics
- Diagnosis162 topics
- Treatment162 topics
- B-Type Natriuretic Peptide121 topic
- Hospital Readmission121 topic
- Acute Coronary Syndromes101 topic
- Myocardial Infarction101 topic
- Chamber Quantification61 topic
- Echocardiography61 topic
- Coronary Stents51 topic
- Myocardial Revascularization51 topic
- Pelvic Floor Dysfunction51 topic
- Urinary Incontinence51 topic
- Aldosterone41 topic
- Antithrombotic Therapy41 topic
- Arrhythmias41 topic
- Long-QT Syndrome41 topic
- Primary Aldosteronism41 topic
- Venous Thromboembolism41 topic
Where does Sebastiano Scalzo work?
Sebastiano Scalzo's main affiliation in the publication record is Ospedale G.F. Ingrassia, Italy.
How many publications and citations does Sebastiano Scalzo have?
OpenAlex counts 43 works and 573 citations for Sebastiano Scalzo, an h-index of 11, ranking #5,967,250 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Sebastiano Scalzo. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.